Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong · Delayed Price · Currency is HKD 5.34
+0.10 (1.91%)
Jun 1, 2026, 4:08 PM HKT
HKG:0512 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 18,349 | 27,489 | 16,809 | 14,394 | 16,225 | 22,930 | |
Market Cap Growth | -26.30% | 63.54% | 16.78% | -11.29% | -29.24% | -6.11% |
Enterprise Value | 19,310 | 29,899 | 18,299 | 16,581 | 18,124 | 22,786 |
Last Close Price | 5.24 | 7.85 | 4.59 | 3.71 | 4.04 | 5.53 |
PE Ratio | 14.79 | 22.15 | 6.81 | 7.66 | 7.80 | 9.54 |
Forward PE | 9.19 | 11.94 | 8.11 | 7.31 | 7.90 | 9.61 |
PS Ratio | 1.49 | 2.24 | 1.44 | 1.37 | 1.70 | 2.67 |
PB Ratio | 1.07 | 1.60 | 1.02 | 0.94 | 1.14 | 1.71 |
P/TBV Ratio | 1.52 | 2.28 | 1.28 | 1.12 | 1.34 | 1.95 |
P/FCF Ratio | 19.87 | 29.77 | 12.52 | 7.43 | 13.34 | 14.95 |
P/OCF Ratio | 11.12 | 16.67 | 8.86 | 5.94 | 8.81 | 11.43 |
EV/Sales Ratio | 1.57 | 2.43 | 1.57 | 1.58 | 1.90 | 2.65 |
EV/EBITDA Ratio | 7.96 | 12.95 | 6.84 | 5.16 | 5.83 | 9.14 |
EV/EBIT Ratio | 10.48 | 16.92 | 8.24 | 5.80 | 6.60 | 10.50 |
EV/FCF Ratio | 20.91 | 32.38 | 13.63 | 8.56 | 14.90 | 14.85 |
Debt / Equity Ratio | 0.28 | 0.28 | 0.27 | 0.22 | 0.32 | 0.27 |
Debt / EBITDA Ratio | 2.01 | 2.01 | 1.63 | 1.05 | 1.42 | 1.46 |
Debt / FCF Ratio | 5.12 | 5.12 | 3.31 | 1.76 | 3.68 | 2.38 |
Net Debt / Equity Ratio | 0.05 | 0.05 | -0.02 | 0.01 | 0.08 | 0.01 |
Net Debt / EBITDA Ratio | 0.35 | 0.35 | -0.13 | 0.04 | 0.37 | 0.06 |
Net Debt / FCF Ratio | 0.86 | 0.86 | -0.27 | 0.07 | 0.94 | 0.10 |
Asset Turnover | 0.47 | 0.47 | 0.49 | 0.47 | 0.44 | 0.45 |
Inventory Turnover | 3.86 | 3.86 | 3.56 | 2.94 | 2.94 | 3.23 |
Quick Ratio | 0.93 | 0.93 | 1.01 | 0.98 | 0.86 | 1.00 |
Current Ratio | 1.14 | 1.14 | 1.22 | 1.22 | 1.07 | 1.22 |
Return on Equity (ROE) | 7.38% | 7.38% | 15.51% | 12.86% | 15.18% | 19.41% |
Return on Assets (ROA) | 4.23% | 4.23% | 5.84% | 7.96% | 7.91% | 7.13% |
Return on Invested Capital (ROIC) | 8.19% | 8.62% | 12.16% | 15.04% | 15.83% | 15.13% |
Return on Capital Employed (ROCE) | 8.90% | 8.90% | 12.10% | 17.00% | 17.30% | 14.00% |
Earnings Yield | 6.76% | 4.51% | 14.69% | 13.06% | 12.82% | 10.48% |
FCF Yield | 5.03% | 3.36% | 7.99% | 13.46% | 7.50% | 6.69% |
Dividend Yield | 3.23% | 2.15% | 5.67% | 7.01% | 3.46% | 1.99% |
Payout Ratio | 73.37% | 73.37% | 36.88% | 26.43% | 18.78% | 16.25% |
Buyback Yield / Dilution | - | - | 0.17% | 0.97% | 0.16% | -2.98% |
Total Shareholder Return | 3.23% | 2.15% | 5.83% | 7.99% | 3.62% | -1.00% |